Bsp Pharmaceuticals Spa
Bsp Pharmaceuticals Spa, headquartered in Italy, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality sterile injectable products. Founded in 2006, the company has rapidly expanded its operational footprint across Europe and beyond, establishing a reputation for excellence in the production of complex formulations. Bsp Pharmaceuticals is renowned for its commitment to innovation and quality, offering a diverse range of services including contract manufacturing and development for both generic and branded products. The company’s state-of-the-art facilities and adherence to stringent regulatory standards set it apart in a competitive market. With a focus on patient safety and efficacy, Bsp Pharmaceuticals has achieved significant milestones, positioning itself as a trusted partner for healthcare providers and pharmaceutical companies alike.
DitchCarbon Score
How does Bsp Pharmaceuticals Spa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bsp Pharmaceuticals Spa's score of 21 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bsp Pharmaceuticals Spa's reported carbon emissions
BSP Pharmaceuticals Spa, headquartered in Italy, has set ambitious climate commitments despite not providing specific carbon emissions data for the most recent year. The company has committed to reducing its absolute greenhouse gas (GHG) emissions by 47% for both Scope 1 and Scope 2 by 2031, using 2021 as the baseline year. Additionally, BSP Pharmaceuticals aims to achieve a 55% reduction in Scope 3 emissions related to capital goods, fuel and energy-related activities, and employee commuting, measured per square metre of operated campus within the same timeframe. These targets align with the science-based targets necessary to limit global warming to 1.5°C, demonstrating BSP Pharmaceuticals' commitment to sustainability and climate action within the pharmaceuticals, biotechnology, and life sciences sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bsp Pharmaceuticals Spa is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
